Navigation Links
Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
Date:11/28/2007

cers and pressure sores.

The '648 patent describes a novel, fully biodegradable and resorbable collagen-based material with improved mechanical, physical and functional properties that has application as a wound covering or surgical implant for the purpose of tissue augmentation and repair where mechanical strength is especially desirable. The material may optionally contain drugs and other bioactive substances for local delivery to the site of implantation or tissue defect.

Commenting on receipt of the notices, Dr. Michael Myers, President and CEO said, "The grant of these two patents will both broaden and strengthen the intellectual property covering our core CollaRx platform technology and particularly its applications in wound healing, biosurgery and local drug delivery. Having now secured both European and US patent rights for our advanced wound care product, DermaSIL, we are intent on scaling-up the proprietary manufacturing process and commercializing this product in 2008 through our CollMED Laboratories joint venture in the US and in collaboration with distribution partners in Europe."

About CollaRx(R)

CollaRx is Innocoll's lead technology platform for the site specific, local delivery of a wide variety of drugs with particular emphasis on antibiotics, anesthetics, anti-cancer agents and tissue regeneration proteins and peptides. The CollaRx technology forms the basis of Innocoll's lead product, Gentamicin Surgical Implant, a biodegradable leave-behind implant indicated for the treatment and prevention of surgical site infection in both hard and soft tissue. This product is already approved in 49 countries and is in phase 3 development in the US. Other CollaRx sponge products under clinical development by Innocoll include a CollaRx Bupivacaine Implant for the management of post-operative pain and a topically-applied CollaRx Gentamicin Sponge for the treatment and prevention of diabetic foot infections. Innocoll's CollaRx membrane
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
8. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
9. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
10. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
11. Prime Therapeutics Receives TIPPS Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Angeles, CA (PRWEB) September 03, 2014 ... is hosting a free webinar called “Google Hates ... the live presentation will reveal common problems that render ... – and offer strategies to overcome them. , The ... 10th, beginning at 11am PST (2 pm EST), and ...
(Date:9/3/2014)... Viejo, California (PRWEB) September 03, 2014 ... new ProStatic Lesson from Pixel Film Studios. , “ProStatic ... TV and VCR static to special effect artist,” said ... users customizable options to create the static distortion based ... static effects of an old television or VCR in ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Londi Palmisano, ... to offer an innovative solution for people looking for ... muscles of the back and upper body. In a ... really innovative and functional design for promoting increased flexibility ... body weight, and a gentle rocking motion. , Then, ...
(Date:9/3/2014)... Mila Carlson, PhD, RN, CLNC, CNLCP, ... healthcare provider. Celebrating 5 years of successful service ... of the National Alliance of Certified Legal ... Consultants, American Association of Legal Nurse Consultants-Greater Chicago ... Care Planners. , Dr. Carlson’s background is ...
(Date:9/3/2014)... Seattle, Wa (PRWEB) September 03, 2014 ... report created by Nguyen Do on the site Vkool.com, ... on health and beauty, and provides detailed instructions on ... of this report, people will discover some reasons to ... soothes chapped lips ,     It may protect against ...
Breaking Medicine News(10 mins):Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 2Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 3Health News:A New ProStatic Lesson was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Body Archer's Solution for Perfect Back Stretching Sparks Interest Among Health Care Pros 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 3Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 2Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 3
... found the survival rate of non-small-cell lung cancer ... adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that ... slows their growth and spread in the body. ... receive either three or four cycles of cisplatin-based ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... dads who have children at an older age may ... in life. ,Researchers based their analysis on ... between 1989 and 2001 with a diagnosis of schizophrenia ... strong association between the fathers' age at conception and ...
... use stomach-acid suppressive medications for indigestion or gastroesophageal reflux ... of developing pneumonia .// ,The use of ... infections, as stomach acidity is a major defense mechanism ... than 364,000 patients who did and did not use ...
... say they have found that the drug toremifene, also ... decreased patients' cancer incidence after 12 months of treatment. ... but the 20-milligram dose had the greatest effect. ... neoplasia, characterized by abnormal cells in the lining of ...
... that sleep disorders may be linked to other medical ... neuromuscular conditions, and psychiatric problems. ,Researchers conducted a ... apnea also had ADD. Results also show a high ... showed some of these patients also suffered severe memory ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
(Date:9/3/2014)... VIENNA , September 3, 2014 /PRNewswire/ ...   to be located in the ... Nabriva Therapeutics AG, a biotechnology company ... antibiotics for the treatment of serious infections caused by ... Broom as Chief Executive Officer (CEO). Current CEO Ralf Schmid will ...
(Date:9/3/2014)... ,    ~ Clinical ... Kiadis Pharma B.V. ("Kiadis Pharma", ... developing T-cell immunotherapy treatments for blood cancers, today announces ... PhD, as its Chief Medical Officer. Jeroen ... Biosciences. Prior to that he was VP Medical Affairs ...
(Date:9/3/2014)... BUDAPEST, Hungary , Sept. 3, 2014 /PRNewswire/ ... "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") announced ... license agreement to co-develop and commercialize bremelanotide for ... Union, other European countries and additional selected countries.  ... a strong focus in female health and annual ...
Breaking Medicine Technology:Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 2Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 3Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 2Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 3Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 4Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 5
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) will ... KeyBanc Capital Markets 2011 Basic Materials ... InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... at the Grand Hyatt, New York, NY, presenting at ...
... SimonMed and Cox Business have partnered to make a ... patients in the Valley and across the state at ... is the first dedicated outpatient offering of breast tomosynthesis ... in Scottsdale. Sub-specialty trained radiologists at SimonMed ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
... BBL CHROMagar MRSA is a differential ... and/or confirmation of MRSA. Selective agents ... gram-negative organisms, most strains of S. ... the chromogenic substrate resulting in mauve ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
... The Apex light source is equipped with a ... higher efficiency light collection and energy transfer from the ... a 730 lumen output, which is equivalent to higher ... use of a lower watt bulb reduces the amount ...
... Understanding the need to standardize your ... a comprehensive line of optical couplers to ... Linvatec offers standard "C and "V mount ... fog free cartridge designs. We also offer ...
Medicine Products: